Home - Cannabis Wire
Oct 30, 2024 · The U.S. Food and Drug Administration hosted an educational webinar on Tuesday titled “FDA Drug Topics: Cannabis Products and the Potential Impact on Patients.”. Much of the webinar was focused on the pharmacology of cannabis, state and federal regulations, quality control, and safety. But in both the main presentation, and in the Q&A period, intoxicating hemp products repeatedly came up.
Posts - Cannabis Wire
October 22, 2024 ⋅ Plus, new polls out of Florida and South Dakota in this excerpt from the latest edition of the Cannabis Wire Daily newsletter.
Florida's Cannabis Legalization Measure Falls Short After …
Nov 6, 2024 · A measure that would’ve made Florida the second most populous state in the U.S. to legalize cannabis for adult use failed to pass. The measure, Amendment 3, needed 60% support – a higher threshold of support than any other adult use measure has faced.
The Cannabis Tipping Point Could Come on Election Day
Nov 4, 2024 · On Tuesday, if Florida voters make their state the 25th to legalize cannabis for adult use, the United States will reach a cannabis tipping point. Still, red states and Republicans, despite former President Donald Trump’s sudden shift, have been slowest to move toward reform. And this year, not ...
Cannabis Wire+ - Cannabis Wire
Access legal and regulatory info for U.S. states and territories. Global Data. Keep up with the legal status of cannabis across the globe.
United States Archives - Cannabis Wire
October 22, 2024 ⋅ Plus, new polls out of Florida and South Dakota in this excerpt from the latest edition of the Cannabis Wire Daily newsletter.
What Are the Cannabis PACs Up To? - Cannabis Wire
Oct 24, 2024 · Cannabis dollars are increasingly making their way into politics, with lobbying spending hitting more than $4 million last year. Now, that same rise in spending can be seen in political action committees. This year, there are about a dozen cannabis-focused PACs, but only a handful of them are ...
Exclusive: Cannabis Wire Goes One-on-One with FDA’s Leading …
Jan 31, 2023 · The U.S. Food and Drug Administration made a headline-grabbing announcement last week: after years of work, the agency concluded that “existing regulatory frameworks” are insufficient for allowing CBD in foods and supplements, and that it aims to work with Congress on a “new regulatory pathway for CBD.”
In Historic Move, DEA Will Recommend Cannabis Reclassification
Apr 30, 2024 · The rescheduling of cannabis, once complete, will mark an historic shift in U.S. cannabis policy, and is likely to send ripple effects across the globe.
Cannabis Research Bills Advance in Congress - Cannabis Wire
Apr 4, 2022 · Just days after the Senate passed a cannabis research bill, the House of Representatives has passed its own. Both bills aim to streamline, and, by extension, expand, cannabis research, but the two bills have some noteworthy differences.